MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
MariMed's free cash flow for the twelve months ending Sep 30, 2026 was $9.13M, up 449.9% year over year. For fiscal 2025 it was $6.53M. The highest annual figure on record is $17.98M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.53M | – |
| FY2024 | Dec 31, 2024 | -$5.18M | – |
| FY2023 | Dec 31, 2023 | -$12.22M | – |
| FY2022 | Dec 31, 2022 | -$4.83M | -126.9% |
| FY2021 | Dec 31, 2021 | $17.98M | – |
| FY2020 | Dec 31, 2020 | -$1.31M | – |
| FY2019 | Dec 31, 2019 | -$33.81M | – |
| FY2018 | Dec 31, 2018 | -$11.83M | – |
| FY2017 | Dec 31, 2017 | -$19.21M | – |
| FY2016 | Dec 31, 2016 | -$3.56M | – |
| FY2014 | Dec 31, 2014 | -$452.56K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.24M | +53.1% |
| Q2 FY2026 | Jun 30, 2026 | $1.92M | – |
| Q1 FY2026 | Mar 31, 2026 | $576.00K | -43.9% |
| Q4 FY2025 | Dec 31, 2025 | $3.40M | – |
| Q3 FY2025 | Sep 30, 2025 | $2.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $1.03M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.47M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.76M | -191.0% |
| Q2 FY2024 | Jun 30, 2024 | -$1.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$158.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.15M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.94M | +59.6% |
| Q2 FY2023 | Jun 30, 2023 | -$4.46M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.55M | -268.7% |
| Q4 FY2022 | Dec 31, 2022 | -$418.00K | -109.5% |
| Q3 FY2022 | Sep 30, 2022 | $1.21M | -72.7% |
| Q2 FY2022 | Jun 30, 2022 | -$10.10M | -940.0% |
| Q1 FY2022 | Mar 31, 2022 | $4.48M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.38M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.45M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.20M | – |
| Q3 FY2020 | Sep 30, 2020 | -$329.05K | – |
| Q2 FY2020 | Jun 30, 2020 | -$410.52K | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.77M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.88M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.92M | – |
| Q2 FY2019 | Jun 30, 2019 | -$18.24M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.76M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.03M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.32M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.31M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.34M | -16717.2% |
| Q3 FY2017 | Sep 30, 2017 | -$5.15M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.67M | – |
| Q4 FY2016 | Dec 31, 2016 | $62.21K | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.15M | – |
See a number that looks wrong?